SPARSH BIOTECH is confidently establishing itself as a crucial player in the medicinal sector, notably recognized for its cutting-edge process of creating Amoxycillin and Augmentin. The organization boasts state-of-the-art infrastructure and a dedicated team providing high-quality drugs reaching